secwatch.observer — SEC 8-K summary
======================================

Issuer:     SERA PROGNOSTICS, INC. (SERA)
CIK:        0001534969
Form:       8-K
Filed at:   2024-11-06T23:59:59+00:00
Accession:  0000950170-24-122288
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sera Prognostics Q3 revenue $29k, net loss $7.9M; PRIME study data locked
-------------------------------------------------------------------------

- Revenue fell to $29k from $42k YoY; net loss widened to $7.9M from $7.2M.
- Operating expenses $8.9M, up 8% YoY; SG&A $5.4M due to growth investments.
- PRIME study database locked in Sept; results planned for 2025 conferences and journal submission.
- Direct-to-consumer PreTRM testing via website launched Oct 1; TV awareness campaign with Dennis Quaid and Meg Ryan.
- Ambient whole blood collection lowers cost of goods and boosts lab capacity for scalability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534969/000095017024122288/0000950170-24-122288-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534969/000095017024122288/sera-20241106.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-122288

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer